CAPROMAB
UNII LZM5W2UC3I

Substance Identification & Data

This profile provides standardized clinical and technical data for Capromab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LZM5W2UC3I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 151763-64-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
LZM5W2UC3I
CAS Registry Number
151763-64-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CAPROMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174682
National Cancer Institute reference terminology for clinical and research data.
INN ID
7201
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Capromab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CAPROMAB

Common Names & Synonyms

CAPROMAB [INN]
CAPROMAB [MI]
CAPROMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROSTATIC CARCINOMA CELL) (MOUSE MONOCLONAL 7E11-C5.3 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL 7E11-C5.3 LIGHT CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus